Mamatha Gaddam

Assistant Professor

University of Arkansas for Medical Sciences

faculty

COM | Internal Med Hem-Onc

3 h-index 19 pubs 52 cited

Research Areas

Lymphoma Diagnosis and Treatment Cancer Treatment and Pharmacology Immune Response and Inflammation Immune Cell Function and Interaction CAR-T cell therapy research Health disparities and outcomes Meta-analysis and systematic reviews Astrophysics and Cosmic Phenomena

Links

Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Mamatha Gaddam is an Assistant Professor in Internal Medicine, Hematology-Oncology at the University of Arkansas for Medical Sciences. Her research focuses on hematological malignancies and related conditions. Recent publications investigate the impact of CAR-T cell therapy on survival in diffuse large B-cell lymphoma, immune checkpoint inhibitor toxicity in older cancer patients, and myelodysplastic syndromes. Gaddam also studies immune effector cell-associated HLH-like syndrome and hyperhemolysis in sickle cell disease. She has collaborated with researchers at her institution, including Ankur Varma, Alan Baltz, Bhavesh Mohan Lal, and Nishanth Thalambedu, on multiple publications. Her work includes epidemiological and clinical trends in common hematological malignancies within Arkansas, utilizing data from the Arkansas Central Cancer Registry.

Metrics

h-index: 3
Publications: 19
Citations: 52

Selected Publications

Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026) DOI
Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025) DOI
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025) DOI
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025) DOI
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025) DOI
Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances (2025) DOI
Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting (2024) DOI
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024) DOI
Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024) DOI
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024) DOI
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms (2023) DOI
Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity (2023) DOI